— Know what they know.
Not Investment Advice

HAE NYSE

Haemonetics Corporation
1W: +1.5% 1M: +13.4% 3M: +40.5% YTD: +50.0% 1Y: +134.1% 3Y: +34.7% 5Y: +72.8%
$119.97
+0.78 (+0.65%)
After Hours: $117.00 (-2.97, -2.48%)
Weekly Expected Move ±9.2%
$97 $108 $118 $129 $140
NYSE · Healthcare · Medical - Devices · Tech Score Strong Buy · Power 78 · $5.5B mcap · 45M float · 1.60% daily turnover · Short 46% of daily vol
Credit Risk of going bust: lower than 51% of companies Debt: 17.8% of company value Bonds: $84.5M held by 32 funds → details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $2.47 (down 98%), Haemonetics Corporation would be worth roughly what it owes.
Total debt $1.17B against a stock market value of $5.42B.
Distance to default 5.19 (Merton model): prices to 2026-10-26, balance sheet 2026-06-27, debt counted $589.6M (short-term plus half of long-term), stock volatility 48.2%; Altman Z 3.37. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
59.8 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 10.1%  ·  5Y Avg: 8.3%
Cost Advantage
60
Intangibles
47
Switching Cost
60
Network Effect
55
Scale ★
85
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. HAE has a Narrow competitive edge (59.8/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Efficient Scale. ROIC of 10.1% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$95
Low
$116
Avg Target
$140
High
Based on 10 analysts since Aug 6, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 12Hold: 9Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$116.40
Analysts10
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-10-09 Mizuho Securities Anthony Petrone $85 $140 +55 +17.3% $119.38
2026-10-09 Barrington — $118 $140 +22 +17.2% $119.47
2026-10-08 BTIG — $96 $130 +34 +12.8% $115.25
2026-09-03 Raymond James Andrew Cooper $105 $125 +20 +21.4% $102.95
2026-08-21 Robert W. Baird — $96 $119 +23 +10.0% $108.22
2026-08-19 Barrington — $95 $118 +23 +12.8% $104.65
2026-08-07 Raymond James — $90 $105 +15 +22.5% $85.73
2026-08-07 Robert W. Baird — $67 $96 +29 +12.9% $85.02
2026-08-07 Barrington — $89 $95 +6 +11.7% $85.02
2026-08-06 BTIG Marie Thibault $88 $96 +8 +13.0% $84.94
2026-06-15 Mizuho Securities Anthony Petrone $70 $85 +15 +8.7% $78.20
2026-05-12 Barrington — $94 $89 -5 +70.4% $52.24
2026-05-08 Robert W. Baird David Rescott $81 $67 -14 +30.0% $51.55
2026-04-13 Mizuho Securities Anthony Petrone $80 $70 -10 +22.0% $57.39
2026-02-06 Robert W. Baird — $99 $81 -18 +31.9% $61.40
2026-02-06 Barrington — $93 $94 +1 +44.6% $65.02
2026-02-06 Mizuho Securities — $90 $80 -10 +23.0% $65.02
2026-01-12 Barrington — Initiated $93 — +13.4% $82.03
2025-12-17 Mizuho Securities — Initiated $90 — +11.0% $81.11
2025-12-15 Robert W. Baird — Initiated $99 — +23.2% $80.33
2025-11-14 Raymond James Andrew Cooper $120 $90 -30 +21.8% $73.91
2025-11-06 BTIG — Initiated $88 — +32.9% $66.20
2025-08-07 Needham Mike Matson $112 $68 -44 +22.2% $55.64
2024-11-08 Raymond James Andrew Cooper Initiated $120 — +60.4% $74.83
2024-09-13 C.L. King Kristen Stewart Initiated $116 — +58.3% $73.26
2024-09-11 Bank of America Securities Craig Bijou Initiated $85 — +18.7% $71.61
2024-06-12 Needham Mike Matson Initiated $112 — +34.3% $83.41

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B
Oct 27, 2026
DCF
4
ROE
4
ROA
4
D/E
1
P/E
1
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. HAE receives an overall rating of B. Strongest factors: DCF (4/5), ROE (4/5), ROA (4/5). Areas of concern: D/E (1/5), P/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-08-10 B- B
2026-08-07 B B-
2026-07-30 B+ B
2026-07-27 B B+
2026-07-25 B+ B
2026-07-16 B B+
2026-07-01 B+ B
2026-06-16 B B+
2026-06-09 B+ B
2026-05-07 A- B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 51 Grade A
Profitability
49
Balance Sheet
51
Earnings Quality
65
Growth
22
Value
43
Momentum
55
Safety
65
Cash Flow
77
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. HAE scores highest in Cash Flow (77/100) and lowest in Growth (22/100). An overall grade of A places HAE among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
2.63
Grey Zone
Piotroski F-Score
8/9
✓ ✓ ✗ ✓ ✓ ✓ ✓ ✓ ✓
Beneish M-Score
-2.87
Unlikely Manipulator
Ohlson O-Score
-6.87
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
A-
Score: 65.4/100
Trend: Deteriorating
Earnings Quality
75/100
OCF/NI: 3.41x
Accruals: -9.6%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. HAE scores 2.63, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. HAE scores 8/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. HAE's score of -2.87 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. HAE's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. HAE receives an estimated rating of A- (score: 65.4/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). HAE's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
58.54x
PEG
-1.57x
P/S
4.06x
P/B
6.53x
P/FCF
12.13x
P/OCF
10.76x
EV/EBITDA
17.16x
EV/Revenue
3.32x
EV/EBIT
29.66x
EV/FCF
15.39x
Earnings Yield
2.73%
FCF Yield
8.24%
Shareholder Yield
5.05%
Graham Number
$29.47
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 58.5x earnings, HAE is priced for high growth expectations. Graham's intrinsic value formula yields $29.47 per share, 307% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.738
NI / EBT
×
Interest Burden
0.863
EBT / EBIT
×
EBIT Margin
0.112
EBIT / Rev
×
Asset Turnover
0.560
Rev / Assets
×
Equity Multiplier
2.808
Assets / Equity
=
ROE
11.2%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. HAE's ROE of 11.2% is driven by Asset Turnover (0.560), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$17.91
Price/Value
4.32x
Margin of Safety
-331.61%
Premium
331.61%
Assessment
Overvalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with HAE's realized 0.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. HAE trades at a 332% premium to its adjusted intrinsic value of $17.91, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 58.5x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$119.99
Median 1Y
$106.80
5th Pctile
$48.83
95th Pctile
$234.41
Ann. Volatility
45.2%
Analyst Target
$116.40
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Christopher A. Simon
President and Chief Executive Officer
$1,100,008 $7,561,987 $12,044,701
James C. D'Arecca
Executive Vice President, Chief Financial Officer
$603,698 $1,841,481 $3,623,016
Michelle L. Basil
Executive Vice President, General Counsel
$558,776 $1,749,291 $3,409,543
Frank W. Chan
Executive Vice President, Chief Operating Officer
$518,263 $1,473,137 $3,336,849
Roy Galvin President,
Vice President, Chief Commercial Officer
$550,205 $1,473,137 $3,039,118

CEO Pay Ratio

82:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $12,044,701
Avg Employee Cost (SGA/emp): $147,033
Employees: 3,009

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
3,009
-0.5% YoY
Revenue / Employee
$443,346
Rev: $1,334,027,000
Profit / Employee
$32,339
NI: $97,308,000
SGA / Employee
$147,033
Avg labor cost proxy
R&D / Employee
$19,862
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Q1'27 Current
ROE 4.6% 3.1% 5.9% 9.4% 12.1% 12.7% 14.7% 16.7% 15.8% 14.7% 13.2% 13.0% 14.0% 14.1% 18.8% 18.3% 19.5% 19.3% 12.0% 11.2% 11.20%
ROA 1.9% 1.4% 2.4% 3.7% 4.7% 5.2% 6.1% 7.2% 6.6% 6.2% 5.7% 5.1% 5.5% 5.5% 7.2% 6.5% 6.8% 7.0% 4.0% 4.0% 3.99%
ROIC 1.8% 1.3% 4.3% 6.1% 7.7% 8.2% 9.8% 10.9% 10.3% 8.3% 8.0% 6.6% 7.2% 7.9% 9.2% 9.2% 10.1% 10.5% 10.4% 10.1% 10.15%
ROCE 6.1% 6.0% 6.3% 7.6% 9.2% 9.4% 9.9% 11.0% 10.6% 10.4% 10.8% 8.9% 9.7% 9.9% 13.2% 13.5% 13.7% 13.4% 8.0% 7.2% 7.19%
Gross Margin 51.2% 53.3% 58.2% 54.3% 53.1% 52.0% 54.0% 53.8% 53.6% 55.0% 55.0% 53.3% 55.3% 57.4% 55.0% 59.7% 56.0% 56.5% 57.2% 59.8% 59.76%
Operating Margin 10.2% 13.7% 7.2% 11.8% 15.7% 14.2% 11.6% 17.2% 11.1% 13.7% 8.7% 11.8% 15.0% 16.9% 15.6% 16.8% 20.6% 20.5% 14.9% 16.9% 16.93%
Net Margin 6.2% 8.9% 3.7% 7.6% 11.2% 10.8% 9.7% 13.2% 7.8% 9.3% 5.9% 11.4% 9.8% 10.8% 17.5% 10.6% 11.8% 13.2% -5.8% 9.7% 9.73%
EBITDA Margin 21.8% 23.1% 21.1% 20.2% 23.8% 21.9% 20.2% 24.6% 20.7% 24.5% 19.9% 23.8% 25.8% 27.3% 29.9% 29.2% 26.5% 28.2% 1.2% 22.0% 22.01%
FCF Margin 5.8% 3.4% 7.6% 8.6% 10.7% 11.3% 13.9% 14.4% 16.1% 10.7% 9.4% 6.0% 3.3% 7.0% 10.5% 14.1% 19.3% 23.4% 19.5% 21.5% 21.54%
OCF Margin 11.7% 11.1% 17.3% 21.0% 23.9% 23.2% 23.4% 20.5% 21.2% 15.5% 13.9% 10.1% 6.2% 9.4% 13.4% 16.8% 21.8% 25.7% 22.0% 24.3% 24.27%
ROE 3Y Avg snapshot only 14.23%
ROE 5Y Avg snapshot only 13.46%
ROA 3Y Avg snapshot only 5.08%
ROIC 3Y Avg snapshot only 7.44%
ROIC Economic snapshot only 9.14%
Cash ROA snapshot only 13.87%
Cash ROIC snapshot only 18.35%
CROIC snapshot only 16.29%
NOPAT Margin snapshot only 13.42%
Pretax Margin snapshot only 9.65%
R&D / Revenue snapshot only 4.40%
SGA / Revenue snapshot only 33.28%
SBC / Revenue snapshot only 2.50%
Valuation
Metric Trend Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Q1'27 Current
P/E Ratio 118.59 120.54 74.85 51.39 44.36 42.07 36.73 32.01 35.89 34.75 37.32 37.13 33.03 30.20 18.75 21.85 13.65 21.50 25.67 36.69 58.539
P/S Ratio 3.97 2.86 3.27 3.39 3.52 3.57 3.63 3.59 3.72 3.46 3.35 3.20 3.00 2.86 2.31 2.65 1.73 2.86 1.87 2.61 4.058
P/B Ratio 5.30 3.73 4.33 4.52 5.24 5.19 5.18 5.06 5.15 4.66 4.57 4.71 4.65 4.33 3.83 4.04 2.70 4.14 3.14 4.22 6.535
P/FCF 68.76 83.19 42.86 39.59 32.82 31.44 26.02 24.87 23.12 32.25 35.64 52.92 89.82 40.95 22.07 18.86 8.97 12.24 9.59 12.13 12.130
P/OCF 33.80 25.75 18.85 16.11 14.71 15.41 15.52 17.47 17.56 22.30 24.14 31.54 48.14 30.39 17.30 15.75 7.94 11.13 8.52 10.76 10.765
EV/EBITDA 23.38 17.78 20.40 18.26 18.35 18.55 18.71 17.58 18.52 17.72 17.11 17.33 15.67 14.53 11.19 11.94 8.61 12.36 12.41 17.16 17.163
EV/Revenue 4.60 3.42 3.79 3.93 4.05 4.05 4.04 3.98 4.05 4.00 3.83 3.86 3.68 3.52 2.99 3.34 2.43 3.51 2.61 3.32 3.316
EV/EBIT 46.48 36.78 41.98 32.20 29.85 29.51 28.20 25.48 26.99 25.19 24.51 25.47 22.88 21.36 16.41 17.21 12.39 17.67 20.63 29.66 29.662
EV/FCF 79.68 99.70 49.74 45.91 37.77 35.68 28.98 27.60 25.18 37.21 40.75 63.83 110.16 50.37 28.52 23.79 12.59 15.04 13.35 15.39 15.395
Earnings Yield 0.8% 0.8% 1.3% 1.9% 2.3% 2.4% 2.7% 3.1% 2.8% 2.9% 2.7% 2.7% 3.0% 3.3% 5.3% 4.6% 7.3% 4.7% 3.9% 2.7% 2.73%
FCF Yield 1.5% 1.2% 2.3% 2.5% 3.0% 3.2% 3.8% 4.0% 4.3% 3.1% 2.8% 1.9% 1.1% 2.4% 4.5% 5.3% 11.2% 8.2% 10.4% 8.2% 8.24%
EV/OCF snapshot only 13.662
EV/Gross Profit snapshot only 5.779
Acquirers Multiple snapshot only 18.244
Shareholder Yield snapshot only 5.05%
Graham Number snapshot only $29.47
Leverage & Solvency
Metric Trend Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Q1'27 Current
Current Ratio 2.42 2.05 1.71 3.81 2.73 3.11 3.06 3.38 3.28 2.92 2.56 3.76 3.49 3.97 1.62 1.72 1.64 1.75 2.95 3.08 3.080
Quick Ratio 1.31 1.19 1.05 2.27 1.76 1.99 2.03 2.16 2.19 1.76 1.50 2.33 2.09 2.55 0.99 1.04 1.03 1.15 1.87 1.91 1.915
Debt/Equity 1.12 1.06 1.04 1.00 1.12 0.99 0.94 0.88 0.85 0.92 0.84 1.35 1.39 1.35 1.49 1.39 1.44 1.34 1.54 1.40 1.403
Net Debt/Equity 0.84 0.74 0.70 0.72 0.79 0.70 0.59 0.55 0.46 0.72 0.66 0.97 1.05 1.00 1.12 1.06 1.09 0.95 1.23 1.14 1.136
Debt/Assets 0.43 0.42 0.42 0.42 0.44 0.41 0.40 0.39 0.38 0.40 0.37 0.48 0.49 0.48 0.50 0.50 0.50 0.49 0.51 0.50 0.496
Debt/EBITDA 4.25 4.23 4.23 3.49 3.42 3.11 3.04 2.77 2.81 3.04 2.75 4.12 3.83 3.68 3.37 3.25 3.27 3.27 4.37 4.50 4.495
Net Debt/EBITDA 3.20 2.94 2.82 2.51 2.41 2.20 1.91 1.74 1.52 2.36 2.14 2.96 2.89 2.72 2.53 2.47 2.48 2.30 3.49 3.64 3.640
Interest Coverage 5.06 4.56 5.24 6.96 7.71 9.76 11.44 16.66 22.60 22.10 15.72 18.45 14.16 10.00 15.37 12.96 12.76 13.51 6.80 4.94 4.941
Equity Multiplier 2.58 2.51 2.48 2.36 2.56 2.42 2.37 2.27 2.25 2.33 2.29 2.81 2.87 2.79 2.99 2.79 2.88 2.73 3.01 2.83 2.826
Cash Ratio snapshot only 0.849
Debt Service Coverage snapshot only 8.539
Cash to Debt snapshot only 0.190
FCF to Debt snapshot only 0.248
Defensive Interval snapshot only 302.6 days
Efficiency & Turnover
Metric Trend Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Q1'27 Current
Asset Turnover 0.58 0.61 0.54 0.57 0.59 0.61 0.62 0.64 0.64 0.62 0.63 0.59 0.60 0.58 0.59 0.54 0.53 0.52 0.55 0.56 0.560
Inventory Turnover 1.49 1.55 1.52 1.55 1.70 1.84 1.98 2.01 2.14 2.08 2.07 1.84 1.85 1.85 1.78 1.58 1.59 1.67 1.70 1.73 1.727
Receivables Turnover 6.60 6.31 6.92 7.35 6.93 6.72 6.90 7.53 7.17 6.47 6.79 7.05 7.02 6.49 6.65 6.69 6.31 6.47 6.36 6.49 6.487
Payables Turnover 9.98 10.00 8.61 8.76 9.23 8.99 8.93 8.38 8.17 9.67 8.70 7.87 8.26 10.25 8.67 9.45 8.72 10.20 9.64 11.26 11.259
DSO 55 58 53 50 53 54 53 48 51 56 54 52 52 56 55 55 58 56 57 56 56.3 days
DIO 244 235 240 235 214 198 185 181 171 175 176 198 198 197 205 231 230 218 215 211 211.4 days
DPO 37 37 42 42 40 41 41 44 45 38 42 46 44 36 42 39 42 36 38 32 32.4 days
Cash Conversion Cycle 263 256 251 243 228 212 197 186 177 194 188 204 205 218 217 247 246 239 235 235 235.2 days
Fixed Asset Turnover snapshot only 4.451
Operating Cycle snapshot only 267.6 days
Cash Velocity snapshot only 6.052
Capital Intensity snapshot only 1.750
Growth (YoY)
Metric Trend Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Q1'27 Current
Revenue 3.5% 7.8% 14.1% 13.6% 16.1% 18.5% 17.7% 18.8% 14.4% 12.5% 12.0% 9.5% 9.8% 8.1% 4.0% 0.9% -2.5% -4.0% -2.0% 0.4% 0.44%
Net Income -70.6% -79.1% -45.4% 5.0% 1.8% 3.2% 1.7% 1.0% 49.1% 32.2% 1.9% -15.9% -3.5% 2.8% 42.6% 42.2% 35.8% 34.9% -42.0% -41.1% -41.05%
EPS -70.8% -79.1% -46.0% 3.5% 1.7% 3.2% 1.7% 1.0% 49.5% 31.6% 1.5% -16.2% -3.2% 4.4% 48.2% 51.6% 46.0% 45.4% -37.9% -37.6% -37.63%
FCF -54.9% -72.2% 5.6% 68.8% 1.2% 2.9% 1.1% 1.0% 71.2% 6.5% -24.4% -54.1% -77.1% -29.7% 15.7% 1.3% 4.6% 2.2% 82.8% 53.9% 53.95%
EBITDA -15.9% -14.4% -5.9% 21.5% 30.4% 34.2% 36.5% 24.9% 13.1% 16.3% 16.3% 7.6% 18.2% 16.1% 23.8% 26.9% 17.0% 12.7% -22.8% -30.7% -30.67%
Op. Income -67.1% -70.5% -10.0% 38.7% 1.9% 2.5% 93.2% 62.5% 26.6% 21.6% 5.7% -15.6% -0.1% 6.0% 22.5% 43.1% 38.4% 34.2% 19.9% 13.7% 13.74%
OCF Growth snapshot only 44.85%
Asset Growth snapshot only -3.93%
Equity Growth snapshot only -5.12%
Debt Growth snapshot only -4.13%
Shares Change snapshot only -5.48%
Growth (CAGR)
Metric Trend Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Q1'27 Current
Revenue 3Y -0.2% 0.0% 0.9% 1.7% 3.1% 4.2% 5.7% 8.8% 11.1% 12.8% 14.6% 13.9% 13.4% 12.9% 11.1% 9.5% 7.0% 5.3% 4.5% 3.5% 3.53%
Revenue 5Y 0.6% 1.1% 2.3% 3.0% 4.0% 4.7% 5.3% 5.7% 5.7% 5.9% 6.2% 6.4% 6.6% 6.6% 6.6% 7.3% 8.0% 8.3% 8.9% 8.4% 8.40%
EPS 3Y 15.0% -20.4% -7.1% 10.6% 8.4% 6.6% 14.7% 12.6% 6.3% 5.3% 13.5% 20.7% 58.5% 80.1% 58.9% 37.1% 28.3% 25.9% -2.2% -7.5% -7.48%
EPS 5Y — 7.3% — 75.0% 81.5% — 21.8% 43.7% 44.2% 23.1% 16.8% 18.2% 13.0% 10.7% 17.8% 12.6% 11.2% 12.1% 6.1% 10.7% 10.72%
Net Income 3Y 13.7% -21.1% -7.6% 11.1% 8.1% 6.3% 14.7% 12.7% 6.5% 5.4% 13.9% 21.2% 58.2% 79.2% 56.9% 34.1% 25.0% 22.4% -5.5% -11.0% -11.00%
Net Income 5Y — 7.0% — 74.2% 80.5% — 20.4% 43.3% 43.3% 22.4% 16.4% 18.4% 12.7% 10.3% 17.0% 11.3% 9.6% 10.2% 4.1% 8.3% 8.35%
EBITDA 3Y 8.5% 1.3% -1.4% 0.2% 1.1% 1.0% -0.8% 6.1% 7.5% 10.1% 14.3% 17.7% 20.3% 21.9% 25.3% 19.5% 16.1% 15.0% 3.6% -1.8% -1.81%
EBITDA 5Y 7.1% 6.8% 8.4% 7.3% 9.2% 13.0% 10.4% 14.7% 13.5% 10.2% 8.7% 6.2% 6.7% 6.8% 7.0% 10.3% 11.4% 11.8% 7.4% 7.5% 7.51%
Gross Profit 3Y 4.2% 5.5% 8.0% 7.4% 8.4% 8.3% 8.5% 11.9% 14.5% 16.7% 18.5% 17.4% 17.0% 16.3% 12.7% 11.1% 8.5% 6.9% 7.1% 6.2% 6.17%
Gross Profit 5Y 2.9% 4.1% 6.8% 8.0% 9.3% 9.5% 8.6% 9.9% 10.0% 10.8% 11.3% 10.0% 9.8% 9.5% 9.1% 10.6% 11.4% 11.6% 12.3% 11.6% 11.65%
Op. Income 3Y -1.1% -18.3% -1.1% 19.2% 14.3% 11.4% 14.7% 11.7% 6.8% 7.5% 22.5% 23.9% 54.8% 64.7% 35.7% 25.2% 20.5% 20.0% 15.8% 11.2% 11.16%
Op. Income 5Y — 4.4% — 84.8% 96.0% — 22.7% 31.9% 29.1% 18.1% 14.6% 18.4% 13.6% 12.3% 14.3% 11.0% 11.0% 12.1% 22.0% 25.3% 25.35%
FCF 3Y -13.0% -23.1% 23.4% 31.0% 31.9% 16.7% 14.2% 13.8% 18.5% 5.1% 19.7% 15.7% -5.5% 43.1% 23.4% 29.1% 30.1% 34.0% 16.9% 18.3% 18.33%
FCF 5Y -2.5% -18.2% -2.0% -2.6% -1.2% 0.3% 2.3% 8.6% 19.5% 13.7% 25.0% 15.6% -2.1% 3.5% 5.4% 9.7% 16.5% 21.2% 29.4% 41.1% 41.11%
OCF 3Y -18.6% -18.6% 2.6% 15.9% 32.6% 25.5% 20.0% 14.3% 16.3% 8.7% 18.7% 12.4% -8.1% 6.9% 1.8% 1.6% 3.7% 9.0% 2.4% 9.5% 9.47%
OCF 5Y -6.7% -9.9% 1.5% 5.2% 6.8% 5.8% 4.4% 4.1% 5.2% 0.1% 2.7% -0.5% -5.3% -0.5% 2.8% 6.2% 11.6% 17.1% 21.9% 28.1% 28.05%
Assets 3Y 12.5% 14.3% 13.4% 13.1% 16.1% 14.9% 15.2% 11.0% 12.4% 18.6% 6.5% 12.3% 11.9% 11.4% 9.6% 10.6% 9.4% 9.9% 7.4% 6.4% 6.43%
Assets 5Y 6.2% 7.0% 8.5% 7.8% 8.0% 7.4% 9.4% 9.6% 9.7% 12.4% 11.5% 15.1% 16.2% 15.4% 14.1% 11.4% 11.5% 13.6% 5.7% 5.7% 5.68%
Equity 3Y -0.1% 4.4% 3.9% 9.2% 7.7% 10.5% 11.7% 12.4% 10.2% 9.5% 9.5% 10.2% 8.0% 7.5% 3.1% 4.6% 5.2% 5.5% -0.9% -1.1% -1.07%
Book Value 3Y 0.9% 5.3% 4.5% 8.8% 8.0% 10.8% 11.7% 12.4% 10.0% 9.4% 9.1% 9.7% 8.1% 8.0% 4.4% 7.0% 8.0% 8.6% 2.6% 2.8% 2.84%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Q1'27 Current
Revenue Stability 0.03 0.04 0.15 0.38 0.43 0.42 0.48 0.58 0.63 0.63 0.64 0.69 0.75 0.79 0.86 0.92 0.93 0.89 0.87 0.85 0.846
Earnings Stability 0.58 0.27 0.43 0.63 0.41 0.34 0.39 0.65 0.43 0.25 0.48 0.53 0.33 0.26 0.63 0.59 0.53 0.53 0.35 0.34 0.339
Margin Stability 0.94 0.93 0.91 0.91 0.91 0.92 0.94 0.92 0.91 0.91 0.91 0.93 0.94 0.94 0.96 0.95 0.94 0.95 0.94 0.94 0.942
Rev. Growth Consistency 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 0.00 0.00 1.00 1.00 0.50 0.50 1.00 0.00 0.00 0.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.50 0.50 0.82 0.98 0.50 0.50 0.50 0.50 0.80 0.87 0.99 0.94 0.99 0.99 0.83 0.83 0.86 0.86 0.83 0.84 0.836
Earnings Smoothness 0.00 0.00 0.41 0.95 0.07 0.00 0.09 0.33 0.61 0.72 0.98 0.83 0.96 0.97 0.65 0.65 0.70 0.70 0.47 0.48 0.483
ROE Trend -0.09 -0.11 -0.06 -0.04 0.02 0.03 0.06 0.07 0.06 0.06 0.02 0.00 0.01 0.01 0.07 0.04 0.06 0.05 -0.04 -0.04 -0.041
Gross Margin Trend 0.02 0.02 0.04 0.05 0.05 0.04 0.02 0.01 0.01 0.02 0.01 0.00 0.01 0.01 0.01 0.03 0.03 0.02 0.03 0.02 0.018
FCF Margin Trend -0.03 -0.07 -0.02 -0.01 0.01 0.03 0.06 0.07 0.08 0.03 -0.01 -0.05 -0.10 -0.04 -0.01 0.04 0.10 0.15 0.10 0.11 0.115
Sustainable Growth Rate 4.6% 3.1% 5.9% 9.4% 12.1% 12.7% 14.7% 16.7% 15.8% 14.7% 13.2% 13.0% 14.0% 14.1% 18.8% 18.3% 19.5% 19.3% 12.0% 11.2% 11.20%
Internal Growth Rate 2.0% 1.5% 2.4% 3.9% 4.9% 5.4% 6.5% 7.8% 7.1% 6.6% 6.0% 5.4% 5.8% 5.8% 7.8% 7.0% 7.3% 7.5% 4.2% 4.2% 4.15%
Cash Flow Quality
Metric Trend Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Q1'27 Current
OCF/Net Income 3.51 4.68 3.97 3.19 3.02 2.73 2.37 1.83 2.04 1.56 1.55 1.18 0.69 0.99 1.08 1.39 1.72 1.93 3.01 3.41 3.408
FCF/OCF 0.49 0.31 0.44 0.41 0.45 0.49 0.60 0.70 0.76 0.69 0.68 0.60 0.54 0.74 0.78 0.84 0.89 0.91 0.89 0.89 0.887
FCF/Net Income snapshot only 3.024
OCF/EBITDA snapshot only 1.256
CapEx/Revenue 6.0% 7.7% 9.7% 12.5% 13.2% 11.8% 9.4% 6.1% 5.1% 4.8% 4.5% 4.1% 2.9% 2.4% 2.9% 2.8% 2.5% 2.3% 2.5% 2.7% 2.73%
CapEx/Depreciation snapshot only 0.336
Accruals Ratio -0.05 -0.05 -0.07 -0.08 -0.09 -0.09 -0.08 -0.06 -0.07 -0.03 -0.03 -0.01 0.02 0.00 -0.01 -0.03 -0.05 -0.07 -0.08 -0.10 -0.096
Sloan Accruals snapshot only 0.023
Cash Flow Adequacy snapshot only 8.885
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Q1'27 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 0.0% 0.0% 0.0% 0.0% 87.2% 78.3% 65.0% 54.9% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 89.5% 91.8% 1.3% 1.3% 1.8% 1.9% 1.85%
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 2.0% 1.9% 1.8% 1.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 4.8% 4.2% 9.8% 6.0% 7.0% 5.1% 5.05%
Net Buyback Yield -0.3% -0.3% -0.1% -0.2% 1.8% 1.7% 1.6% 1.5% -0.1% -0.1% -0.1% -0.1% -0.1% -0.2% -17.7% -15.6% -21.0% -12.8% 6.7% 4.8% 4.84%
Total Shareholder Return -0.3% -0.3% -0.1% -0.2% 1.8% 1.7% 1.6% 1.5% -0.1% -0.1% -0.1% -0.1% -0.1% -0.2% -17.7% -15.6% -21.0% -12.8% 6.7% 4.8% 4.84%
DuPont Factors
Metric Trend Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Q1'27 Current
Tax Burden (NI/EBT) 0.52 0.42 0.68 0.73 0.76 0.77 0.82 0.82 0.81 0.79 0.77 0.78 0.78 0.79 0.79 0.78 0.77 0.77 0.76 0.74 0.738
Interest Burden (EBT/EBIT) 0.65 0.60 0.71 0.74 0.77 0.80 0.84 0.88 0.86 0.80 0.74 0.73 0.72 0.73 0.86 0.80 0.83 0.87 0.76 0.86 0.863
EBIT Margin 0.10 0.09 0.09 0.12 0.14 0.14 0.14 0.16 0.15 0.16 0.16 0.15 0.16 0.16 0.18 0.19 0.20 0.20 0.13 0.11 0.112
Asset Turnover 0.58 0.61 0.54 0.57 0.59 0.61 0.62 0.64 0.64 0.62 0.63 0.59 0.60 0.58 0.59 0.54 0.53 0.52 0.55 0.56 0.560
Equity Multiplier 2.36 2.17 2.48 2.50 2.57 2.46 2.42 2.31 2.39 2.37 2.32 2.54 2.56 2.56 2.61 2.80 2.87 2.76 3.00 2.81 2.808
Per Share
Metric Trend Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Q1'27 Current
EPS (Diluted TTM) $0.61 $0.44 $0.84 $1.31 $1.67 $1.87 $2.25 $2.66 $2.50 $2.46 $2.29 $2.23 $2.42 $2.57 $3.39 $3.38 $3.53 $3.73 $2.11 $2.11 $2.11
Book Value/Share $13.58 $14.23 $14.59 $14.91 $14.14 $15.15 $15.97 $16.84 $17.39 $18.34 $18.67 $17.56 $17.15 $17.91 $16.59 $18.25 $17.82 $19.40 $17.23 $18.32 $18.45
Tangible Book/Share $-2.09 $-1.20 $-0.55 $0.03 $-0.55 $0.50 $1.48 $2.54 $3.46 $-0.80 $-0.22 $-3.94 $-4.39 $-3.24 $-4.83 $-3.63 $-3.89 $-2.45 $-6.66 $-5.56 $-5.56
Revenue/Share $18.15 $18.57 $19.34 $19.85 $21.02 $22.05 $22.82 $23.73 $24.11 $24.69 $25.46 $25.87 $26.57 $27.12 $27.50 $27.84 $27.86 $28.06 $28.86 $29.58 $29.81
FCF/Share $1.05 $0.64 $1.48 $1.70 $2.26 $2.50 $3.18 $3.42 $3.87 $2.65 $2.39 $1.56 $0.89 $1.89 $2.88 $3.91 $5.37 $6.56 $5.63 $6.37 $6.42
OCF/Share $2.13 $2.06 $3.35 $4.18 $5.03 $5.11 $5.33 $4.87 $5.10 $3.83 $3.54 $2.62 $1.66 $2.55 $3.67 $4.69 $6.06 $7.21 $6.34 $7.18 $7.23
Cash/Share $3.74 $4.61 $5.05 $4.16 $4.68 $4.37 $5.55 $5.57 $6.83 $3.77 $3.48 $6.68 $5.84 $6.34 $6.20 $6.06 $6.22 $7.73 $5.31 $4.89 $4.92
EBITDA/Share $3.57 $3.58 $3.60 $4.27 $4.64 $4.81 $4.92 $5.37 $5.27 $5.57 $5.70 $5.76 $6.25 $6.57 $7.34 $7.79 $7.86 $7.98 $6.06 $5.72 $5.72
Debt/Share $15.17 $15.14 $15.20 $14.90 $15.86 $14.97 $14.95 $14.90 $14.83 $16.92 $15.71 $23.73 $23.91 $24.19 $24.76 $25.33 $25.70 $26.07 $26.49 $25.69 $25.69
Net Debt/Share $11.43 $10.52 $10.15 $10.74 $11.18 $10.60 $9.40 $9.33 $8.00 $13.15 $12.24 $17.05 $18.07 $17.85 $18.55 $19.27 $19.48 $18.33 $21.18 $20.80 $20.80
Academic Models
Metric Trend Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Q1'27 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 2.631
Altman Z-Prime snapshot only 4.804
Piotroski F-Score 5 5 6 8 7 8 8 7 9 7 6 4 5 6 5 7 6 5 6 8 8
Beneish M-Score -2.35 -2.37 -2.76 -2.85 -2.76 -2.73 -2.68 -2.56 -2.79 -2.42 -2.43 -2.26 -2.08 -2.47 -2.48 -2.65 -2.75 -2.84 -2.81 -2.87 -2.872
Ohlson O-Score snapshot only -6.870
Net-Net WC snapshot only $-15.70
EVA snapshot only $2620500.37
Credit
Metric Trend Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Q1'27 Current
Credit Rating snapshot only A-
Credit Score 66.08 53.33 57.05 74.57 75.82 80.67 82.29 85.18 86.44 80.42 82.84 71.63 70.32 69.27 62.35 69.06 67.13 72.09 62.61 65.45 65.449
Credit Grade snapshot only 7
Credit Trend snapshot only -3.611
Implied Spread (bps) snapshot only 175.000
Industry Credit Rank snapshot only 64
Sector Credit Rank snapshot only 61

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms